Atlas Trials

mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Clinical trial NCT04781270 · UNKNOWN

Trial details

NCT number
NCT04781270
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal CarcinomaLiver Metastases
Start date
2021-04-15
Primary completion
2024-03-30
Enrollment
308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.